Physiological function in children with stunting in rural Zimbabwe
Physiological function in children with stunting in rural Zimbabwe
批准号:
MR/Y003543/1
负责人:
Andrew Prendergast
金额:
$121.68万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
全球四分之一的儿童受到营养不良的影响。发育迟缓,当儿童长得不像他们的年龄应有的高度时,会由于高血压、心脏病发作和糖尿病等疾病而导致成年后健康不佳。由于这些情况常常同时发生在同一个人身上,我们称之为“多发病”。我们并不完全理解为什么生长不良会增加患这些疾病的风险,但我们想要检验这样一种理论,即身材矮小会伴随着重要器官的发育和功能不良。我们想要探索器官损伤的迹象是否在儿童时期就已经明显,以及密集的营养干预--帮助儿童在生命的前两年长得更高--是否也有助于他们的肌肉、骨骼和器官在9岁时更健康地生长。我们认为,发育迟缓儿童的炎症(身体对伤害或感染的正常反应)过度,进一步损害关键器官的发育和功能,并导致终身健康不良的风险。如果这是真的,光靠营养干预可能是不够的,我们需要找到新的方法来应对身体的炎症反应,以阻止进一步的器官损害。我们将跟踪调查津巴布韦农村地区的一组儿童,他们参加了之前的一项临床试验,该试验随机(像掷硬币一样)让一些儿童在出生后18个月接受营养补充剂,并让一些儿童接受他们常规的家庭饮食。接受营养补充剂的儿童长得更高,在18个月大时不太可能发育迟缓。这些孩子现在都9岁了,这为我们提供了一个机会来研究发育迟缓的长期影响,并探索营养干预是否对健康有持续的好处。我们将对儿童的肌肉质量、骨强度、肺大小、心脏功能、肾脏长度、体内脂肪含量以及儿童控制血糖水平的能力进行详细测试,看看发育不良是否会影响儿童在童年中期的身体机能。这些可能是终生患病风险的“早期预警信号”,因为我们知道,例如,儿童肺的大小可以追溯到成年人的生活,而肺功能不佳与过早死亡的风险有关。我们可以比较早期服用或未服用营养补充剂的儿童的测试结果,看看因补充营养补充剂而长得更高的儿童现在是否有更强壮的骨骼和肌肉,更大的肺和肾脏,更好的心脏功能和更少的体脂。最后,通过使用9岁时收集的血液样本,我们可以检验我们的理论,即高水平的炎症在儿童时期持续存在,并与器官功能下降有关。如果发育迟缓的儿童在学龄期出现器官功能不良的迹象,那么这表明发育迟缓对心脏病等成人疾病的终生影响在儿童时期就已经显现出来。我们认为预防应该在生命的早期就开始。如果我们发现营养补充剂对儿童的骨骼、肌肉和器官有长期的好处,这就向政策制定者发出了一个非常有力的信息:我们应该加大力度,在儿童出生后不久就补充儿童的饮食,因为这种好处可能会延伸到童年中期甚至更久。如果我们发现身体的炎症过程正在推动持续的器官损伤,那么我们可能仍然有机会在学龄期进行干预,阻止这种损伤的进展,而不是等待高血压和糖尿病等疾病在成人生活中变得明显。这项研究将提供我们所需的信息,以设计能够应对炎症的新方法--例如改变饮食、锻炼计划或消炎药--以遏制损害,并确保所有儿童都能成为健康和有生产力的成年人。
英文摘要
Undernutrition affects a quarter of children globally. Stunting, when children do not grow as tall as they should for their age, leads to ill-health into adult life due to diseases like high blood pressure, heart attacks and diabetes. Since these conditions often occur together in the same person, we call this "multimorbidity". We do not fully understand why poor growth increases the risk of these diseases, but we want to test the theory that short stature is accompanied by poor growth and function of vital organs. We want to explore whether signs of organ damage are already apparent in childhood, and whether an intensive nutrition intervention - which helped children to grow taller in the first 2 years of life - also helps their muscles, bones, and organs grow more healthily by the time they reach 9 years of age. We believe that inflammation (the body's normal response to wounding or infection) is excessive in children with stunting, further damaging the development and function of key organs, and leading to a lifelong risk of ill-health. If this is true, nutrition interventions alone may not be enough, and we need to find new ways to tackle the body's inflammatory response to stop further organ damage.We will follow up a group of children in rural Zimbabwe who were enrolled into a previous clinical trial, which randomised (like the flip of a coin) some children to receive nutritional supplements in the first 18 months of life, and some children to receive their regular household diet. The children who received the nutritional supplements grew taller and were less likely to be stunted at 18 months of age. These children are now turning 9 years old, and this provides a chance for us to investigate the long-term effects of stunting, and to explore whether the nutrition intervention has sustained health benefits. We will do detailed testing of children's muscle quality, bone strength, lung size, heart function, kidney length, the amount of fat in the body, and how well a child can control their blood sugar levels, to see whether poor growth affects how children's bodies function by mid-childhood. These might be 'early warning signs' of a lifelong risk of disease, because we know that the size of a child's lungs, for example, tracks into adult life, and that poor lung function is linked to a risk of early death. We can compare test results between children who did or did not get the nutritional supplements in early life, to see whether the children who grew taller due to the supplements now have stronger bones and muscles, bigger lungs and kidneys, better heart function, and less body fat. Finally, by using blood samples collected at 9 years of age, we can test our theory that high levels of inflammation persist during childhood and are associated with reduced organ function. If children with stunting have signs of poor organ function at school age, then it suggests the lifelong impact of stunting on adult diseases like heart attacks is already emerging in childhood. We think prevention should start very early in life. If we find that the nutritional supplements have had long-term benefits for children's bones, muscles and organs, this provides a very powerful message to policymakers: we should be scaling up our efforts to supplement children's diets soon after birth, because the benefits may stretch into mid-childhood and beyond. If we find that the body's inflammatory processes are driving ongoing organ damage, there may still be an opportunity to intervene at school age, to stop progression of this damage, rather than waiting for conditions like high blood pressure and diabetes to become apparent in adult life. This study would provide the information we need to design new approaches that can tackle inflammation - such as dietary changes, exercise programmes, or anti-inflammatory drugs - to halt the damage, and ensure that all children can become healthy and productive adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A community-designed play intervention to enhance early child development in rural Zimbabwe
-
批准号:MR/Y503290/1
-
项目类别:Research Grant
-
资助金额:$19.75万
-
财政年份:2023
-
负责人:Andrew Prendergast
-
依托单位:
Cognitive function in HIV-exposed uninfected children in rural Zimbabwe
-
批准号:MR/X022005/1
-
项目类别:Research Grant
-
资助金额:$139.58万
-
财政年份:2023
-
负责人:Andrew Prendergast
-
依托单位:
The impact of microbial and inflammatory exposures on birth outcomes in rural Zimbabwe
-
批准号:MR/T039337/1
-
项目类别:Research Grant
-
资助金额:$149.73万
-
财政年份:2021
-
负责人:Andrew Prendergast
-
依托单位:
Child Health, Agriculture and Integrated Nutrition (CHAIN): a randomized trial to close the nutrient gap in rural Zimbabwe
-
批准号:BB/S013997/1
-
项目类别:Research Grant
-
资助金额:$236.88万
-
财政年份:2019
-
负责人:Andrew Prendergast
-
依托单位:
Interdisciplinary interventions for stunting and wasting in Zimbabwe, Zambia and Pakistan
-
批准号:MC_PC_MR/R019436/1
-
项目类别:Research Grant
-
资助金额:$24.93万
-
财政年份:2018
-
负责人:Andrew Prendergast
-
依托单位:
Mechanisms underlying enhanced infection prophylaxis for advanced HIV in Africa
-
批准号:MR/P022251/1
-
项目类别:Research Grant
-
资助金额:$105.25万
-
财政年份:2017
-
负责人:Andrew Prendergast
-
依托单位:
The role of enteropathy in the pathogenesis of severe acute malnutrition in HIV-infected African children
-
批准号:MR/K012711/1
-
项目类别:Research Grant
-
资助金额:$98.54万
-
财政年份:2014
-
负责人:Andrew Prendergast
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
双硫仑结合并抑制谷氨酸脱氢酶1活性调节Th17/Treg细胞平衡的作用与机制探究
-
批准号:82371755
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王秦兰
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位: